Wednesday, May 1, 2024

The Ozempic effect

Today's Big Take is here.

May 1, 2024

Novo's factory expansion is transforming Danish town Kalundborg. Photographer: Carsten Snejbjerg/Bloomberg

Read the story

Blockbuster weight-loss drugs have transformed Novo Nordisk into Europe's most valuable company and an icon in its home country, Denmark. The drugmaker's meteoric rise has also been a boon for the economy, which would have stagnated last year without Novo's massive investments, expanding production and $2.3 billion corporate tax injection.

But its enormous scale and influence also comes with risks for the company and country, making it particularly vulnerable to public backlash or regulatory shifts. CEO Lars Fruergaard Jorgensen says he's realistic about these delicate dynamics: "When you have superpowers, you have super responsibility." 

Read The Big Take.

Listen to the podcast

After delivering a dovish surprise in December, Federal Reserve Chair Jerome Powell is poised for a further hawkish tilt at today's Fed meeting as demand holds up and inflation hovers above target. On today's Big Take podcast, host David Gura talks with Fed editor Kate Davidson and Bloomberg Economics' Anna Wong about what to expect.

Subscribe and listen on iHeart, Apple and Spotify.

No comments:

Post a Comment

Germany stays cool to an Italian come-on

Plus: Rate cuts in the real world View in browser Germany's Commerzbank has been in the news o...